key: cord-0812163-tycjt1b3
authors: Rego, N.; Costabile, A.; Paz, M.; Salazar, C.; Perbolianachis, P.; Spangemberg, L.; Ferres, I.; Arce, R.; Fajardo, A.; Arleo, M.; Possi, T.; Bellini, I.; Bilbao, L.; Reyes, N.; Bentancor, M. N.; Lizosain, A.; Benitez, M. J.; Castells, M.; Victoria, M.; Maya, L.; Bortagaray, V.; Moller, A.; Bello, G.; Arantes, I.; Brandes, M.; Smircich, P.; Chappos, O.; Duquia, M.; Gonzalez, B.; Griffero, L.; Mendez, M.; Techera, M. P.; Zanetti, J.; Rivera, B.; Maidana, M.; Alonso, M.; Alonso, C.; Medina, J.; Albornoz, H.; Colina, R.; Noya, V.; Iraola, G.; Fernandez-Calero, T.; Moratorio, G. A.; Moreno, P.
title: Implementation of a qPCR assay coupled with genomic surveillance for real-time monitoring of SARS-CoV-2 variants of concern.
date: 2021-05-22
journal: nan
DOI: 10.1101/2021.05.20.21256969
sha: d80af6e1321ca9e80037cc448adfa6e9b23ef19b
doc_id: 812163
cord_uid: tycjt1b3

We developed a genomic surveillance program for real-time monitoring of SARS-CoV-2 variants of concern in Uruguay. Here, we present the first results, including the proposed qPCR-VOC method, the general workflow and the report of the introduction and community transmission of the VOC P.1 in Uruguay in multiple independent events.

Throughout the pandemic, as part of the natural viral evolution, genetic variants of SARS-CoV-2 have emerged. Some of these have shown increased transmissibility, more severe disease with increased hospitalizations, intensive care units admissions and deaths, significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines and/or diagnostic detection failures [1, 2] . These are called variants of concern (VOCs). Surveillance data from Brazil demonstrated a sharp increase in the number of SARS-CoV-2 cases, hospitalisations and deaths after the emergence of the VOC P.1 in the Amazonas state in November 2020 [4, 5] . The VOC P.1 displays a higher transmissibility than previous local SARS- 5] and rapidly spread through the country, becoming the predominant strain in most country regions by February-March, 2021 [6] . This VOC has also spread worldwide and as of 4 May 2021, the lineage P.1 has been detected in at least 41 countries worldwide [7] . This raises the concern that VOC P.1 might follow in other countries the same epidemic trajectory observed in Brazil.

Uruguay, which shares 600 miles of dry border with Brazil and hosts more than 170,000 people living in twin cities with intense economic and social interaction, has experienced an exponential increase of COVID-19 cases since late

The rapid emergence of the SARS-CoV-2 lineage P.1 in the South American region requires the need for increased screening of this highly transmissible virus. Here we developed a comprehensive genomic surveillance program and provide a clear example of how multidisciplinary teams are key mechanisms for helping sanitary authorities to better manage the crisis. Thus, we created an inter-institutional working group with diagnostic laboratories, hospitals (public and private), public and academic institutions across Uruguay that allows real-time VOCs surveillance. Our findings revealed that the VOC P.1 was introduced in Uruguay at multiple times over a period of increasing mobility between mid-February and early March, 2021. The introduction of the highly transmissible VOC P.1 coupled to the increasing human mobility probably contributed to the rapid local spread of this variant and to the COVID-19 epidemic worsening in Uruguay in 2021. Additionally, the asterisk marks whether the amino acid replacement is considered radical. See Supplementary Table 3 for more details on the clades and synapomorphies.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 using 0.4X volume of AMPure XP beads (Beckman coulter, USA) and quantified using the Qubit HS dsDNA kit (Thermo Fisher Scientific Inc., MA, USA). AMII sequencing adapters were ligated using the NEBNext Quick Ligation Module (New England Biolabs, Ipswich, MA, USA) and washed with SFB buffer (Oxford Nanopore Technologies, United Kingdom). Final library was eluted on EB buffer (Oxford Nanopore Technologies, United Kingdom) and quantified using the Qubit HS dsDNA kit. Approximately 50 fmol was loaded into a FLO-MIN106D R9.4.1 flow cell and sequenced on the GridION X5 sequencing platform (ONT) until a minimum sequencing depth of 500X was achieved.

Basecalling and demultiplexing was performed with Guppy 4.3.2 [5] using the high accuracy mode. Samples were demultiplexed using both front and rear barcodes using the --requiere_both_barcodes option. Consensus genomes were generated and using the poreCov pipeline [6, 7] implemented in Nextflow [8] , which includes the Artic Network workflow [9] , Pangolin for PANGO lineage [10] assignment, nextclade for clade assignment [11] , Kraken2 and Krona for contamination detection and visualization [12, 13] , minimap2 for read mapping [14] , medaka for consensus generation, and using singularity as container engine [15] . Amplicons that are not sequenced or whose depth is less than 20x are not included in the consensus sequences and these positions are represented by "N" stretches. Complete sequences with up to 15% of Ns were kept for further analysis. All genomes obtained in this study were uploaded to the EpiCoV database in the GISAID initiative under the accession numbers: EPI_ISL_1992241, EPI_ISL_1992100, EPI_ISL_1991974, and EPI_ISL_2031707 to EPI_ISL_2031762 and additional metadata for Uruguayan genomes is presented in Supplementary Table 1. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

Uruguayan P.1 genome sequences (n = 59) were manually curated in specific genome positions of interest, such as P.1 synapomorphies, and were analyzed in the context of additional P.1 sequences from South America, downloaded from EpiCoV database in the GISAID initiative [16] . Downloaded sequences (n = 905, see Supplementary GISAID Acknowledgment Table) were complete, high quality, with full collection date information and sampled before March 31, 2021. Alignment was performed with MAFFT v7.471 [17] . After carefully alignment inspection, several sequences were missing the characteristic indels (del11288-11296 and ins28269-28273) of P.1 and were excluded, retaining 691 sequences from Brazil (n = 590), Chile (n = 72), Colombia (n = 4), French Guiana (n = 15), Peru (n = 2) and Suriname (n = 8) (Supplementary Table 2 ). Maximum likelihood (ML) phylogenetic analysis of P.1 samples was conducted using IQ-TREE version 1.6.12 under the GTR+F+R3 nucleotide substitution model selected by the built-in ModelFinder option [18] . Branch support was assessed by the approximate likelihood-ratio test based on a Shimodaira-Hasegawa-like procedure with 1,000 replicates. The tree was rooted using the sequence EPI_ISL_833137 with collection date 2020-12-04 and visualized using iTOL [19] . ML phylogeographic analysis and time-scaled Bayesian analysis were next performed to infer the geographical source of Uruguayan P.1 samples and to estimate the time of the most recent common ancestors (T MRCA ) of the Uruguayan P.1 clades, respectively. The previously generated ML phylogenetic tree was . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 22, 2021. ; https://doi.org/10.1101/2021.05.20.21256969 doi: medRxiv preprint

TA -*Clade UY-V is defined by two synapomorphies, one being the non-synonymous S:L303F change in the spike protein. This change has been reported before, being present in 41 sequences in Europe and USA (mainly in B.1.1.7 sequences) and involves a radical replacement regarding amino acid volume and aromaticity. Other radical changes here described have not been reported in South America before, except for NSP3:T864I (radical replacement in polarity; previously found in Brazil and Chile) and NSP3:V1795F (radical replacement in volume and aromaticity; previously found in Brazil). 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Sequences from Colombia and Peru are colored violet.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table   . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Hospital Nipo Brasileiro Instituto Adolfo Lutz, Interdiciplinary Procedures Center, Strategic Laboratory Claudio Tavares Sacchi, Claudia Regina Gonçalves, Erica Valessa Ramos Gomes, Karoline Rodrigues Campos, Caio Vinicius Dias Lopes EPI_ISL_1358288, EPI_ISL_1358289, EPI_ISL_1358290 IAL Regional de Aracatuba Instituto Adolfo Lutz

South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213178 2021-02-01 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213180 2021-02-01 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213182 2021-02-01 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213183 2021-01-29 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213185 2021-01-28 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213187 2021-01-28 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213189 2021-01-27 2021-03-11 South America / Brazil / Paraíba / Conde EPI_ISL_1213190 2021-01-26 2021-03-11 South America / Brazil / Amazonas / Manaus EPI_ISL_1213192 2021-01-26 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213194 2021-01-26 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213196 2021-01-26 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213197 2021-01-26 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213199 2021-01-26 2021-03-11 South America / Brazil / Rio Grande do Norte / Natal EPI_ISL_1213201 2021-01-21 2021-03-11 South America / Brazil / Paraíba / Joao pessoa EPI_ISL_1213202 2021-01-18 2021-03-11 South America / Brazil / Amazonas / Manaus EPI_ISL_1213204 2021-01-18 2021-03-11 South America / Brazil / Amazonas / Manaus EPI_ISL_1213206 2021-01-18 2021-03-11 South America / Brazil / Amazonas / Manaus EPI_ISL_1213207 2021-01-11 2021-03-11 South America / Brazil / Paraíba / Inga EPI_ISL_1219021 2021-02-24 2021-03-11 South America / Brazil / Sao Paulo / Sao Paulo EPI_ISL_1219025 2021-02-02 2021-03-11 South America / Brazil / Sao Paulo / Guapiara EPI_ISL_1219029 2021-01-23 2021-03-11 South America / Brazil / Sao Paulo / Guarulhos EPI_ISL_1219030 2021-01-23 2021-03-11 South America / Brazil / Sao Paulo / Guarulhos EPI_ISL_1219033 2021-01-22 2021-03-11 South America / Brazil / Sao Paulo / Guarulhos EPI_ISL_1219036 2021-01-21 2021-03-11 South America / Brazil / Sao Paulo / Guarulhos EPI_ISL_1219133 2021-01-26 2021-03-11 South America / Brazil / Parana / Curitiba EPI_ISL_1219134 2021-01-27 2021-03-11 South America / Brazil / Alagoas / Maceio EPI_ISL_1219135 2021-01-27 2021-03-11 South America / Brazil / Alagoas / Maceio EPI_ISL_1219136 2021-02-15 2021-03-11 South America / Brazil / Bahia / Salvador EPI_ISL_1239012 2021-01-26 2021-03-13 South America / Brazil / Amazonas / Manaus EPI_ISL_1239119 2021-01-26 2021-03-14 South America / Brazil / Espirito Santo / Lorena EPI_ISL_1239137 2021-03-01 2021-03-14 South America / Brazil / Minas Gerais / Monte Alegre de Minas EPI_ISL_1239138 2021-03-02 2021-03-14 South America / Brazil / Minas Gerais / Montes Claros EPI_ISL_1261683 2021-01-19 2021-03-16 South America / Brazil / Amazonas EPI_ISL_1261684 2021-02-15 2021-03-16 South America / Brazil / Ceara EPI_ISL_1261685 2021-01-20 2021-03-16 South America / Brazil / Amazonas EPI_ISL_1261686 2021-01-31 2021-03-16 South America / Brazil / Amapa EPI_ISL_1261687 2021-02-15 2021-03-16 South America / Brazil / Roraima EPI_ISL_1261688 2021-02-15 2021-03-16 South America / Brazil / Amapa EPI_ISL_1261689 2021-02-15 2021-03-16 South America / Brazil / Amapa EPI_ISL_1261690 2021-01-11 2021-03-16 South America / Brazil / Amazonas EPI_ISL_1261691 2021-02-11 2021-03-16 South America / Brazil / Para EPI_ISL_1261692 2021-02-08 2021-03-16 South America / Brazil / Amapa EPI_ISL_1261693 2021-02-15 2021-03-16 South America / Brazil / Ceara

South America / Brazil / Amazonas / Manaus EPI_ISL_906081 2021-01-22 2021-01-31 South America / Brazil / Amazonas / Manaus EPI_ISL_918499 2020-12-21 2021-02-03 South America / Brazil / Amazonas EPI_ISL_918500 2020-12-28 2021-02-03 South America / Brazil / Amazonas EPI_ISL_918501 2020-12-28 2021-02-03 South America / Brazil / Amazonas EPI_ISL_918502 2020-12-29 2021-02-03 South America / Brazil / Amazonas

Tiago Gräf EPI_ISL_1445071 USF TRES PONTES Instituto Butantan / Mendelics Dimas Tadeu Covas

Marilda Siqueira on behalf of the Fiocruz COVID-19 Genomic Surveillance Network

EPI_ISL_1534016 Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ Laboratory of Respiratory Viruses and Measles

Marilda Siqueira on behalf of the Fiocruz COVID-19 Genomic Surveillance Network

EPI_ISL_1541015 see above Genetica Molecular and Subdepartamento de Virologia ISP Chile Instituto de Salud Publica de Chile Javier Tognarelli, Karen Orostica, Barbara Parra, Loredana Arata

FCA/UNESP) e Biologia Molecular (FMB-HC/UNESP) -Rede de Vigilância Genômica

EPI_ISL_1583733 see above Central Public Health Laboratory -LACEN -Bahia

EPI_ISL_1608171 see above Hospital São Rafael -IDOR Hospital São Rafael -IDOR Carolina Kymie Vasques Nonaka, Tiago Gräf, Camila Araújo de Lorenzo Barcia